Technical Services
Gene Editing and Rapid Propagation
Comprehensive Experimental Services
Product Center
Aniphe BioLab
About Us
Aniphe BioLab Inc.
Aniphe Biolaboratory Inc. was established in 2018 and is committed to becoming an internationally renowned preclinical pharmacology evaluation company in the new era of biopharmaceutical development. The company has built a comprehensive SPF‑grade laboratory animal center that integrates animal production and experimental services, focusing on laboratory animals and related research support. Its services encompass contract breeding and husbandry, cryopreservation and purification of genetically edited animal models, construction of human disease‑specific animal models, and pharmacological and toxicological testing, covering multiple research areas including oncology, neuroscience, and metabolism. Aniphe BioLab has established a complete R&D, manufacturing, and sales system and management framework, guided by market demand and upholding the principles of pragmatism, truth‑seeking, and mutual benefit. By fostering collaboration among industry, academia, and research institutions, the company drives innovation, serves the life sciences research community and the new‑drug development sector, and contributes to human health and well‑being.
Company area
Number of squirrel cages
Service Cases
News and Updates
2026-04-21
About Us
Partner with us
Why choose Aniphe BioLab?
Compliance Qualification Assurance
The company has earned numerous prestigious honors and certifications, including the “License for the Use of Laboratory Animals,” the “License for the Production of Laboratory Animals,” the “Quality Management System Certification,” as well as designations such as “National High-Tech Enterprise,” “Private Science and Technology Enterprise of Jiangsu Province,” and “National-Level Small and Medium-Sized Science and Technology Enterprise.” These credentials provide robust assurance, solidify the foundation of scientific research, and ensure data compliance suitable for new drug applications.
Mature technology system
A robust platform for model development and breeding, with over 10,000 successful case studies, high model success rates, and strong batch-to-batch consistency. Holder of prestigious honors and certifications, including “Private Science and Technology Enterprise of Jiangsu Province” and “National-Level Technology-Based SME,” we provide rigorous quality assurance to solidify our research foundation. Our data‑compliant solutions are fully eligible for new drug registration submissions.
Efficient delivery capability
5,000+ cage‑space SPF‑grade animal facilities, ample inventory and rapid breeding capabilities ensure on‑demand delivery without delaying your project timeline.
End-to-end quality assurance
Dedicated QA provides end-to-end project oversight, conducting compliance reviews from proposal design and execution to data delivery, and offering risk identification and quality‑enhancement recommendations.
Some partners














Su Public Security Bureau Internet Information Service Filing No. 32010402001421